Please provide your email address to receive an email when new articles are posted on . Patients with asthma who switched from a metered-dose inhaler to a dry-powder inhaler cut their inhaler carbon ...
GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals AstraZeneca AZN and Boehringer ...
(Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker said on ...
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following ...
Asthma sufferers could sharply reduce their carbon footprint by swapping commonly used inhalers for “greener” alternatives, a study from the University of Cambridge has found. By swapping metered-dose ...
Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...
March 18 (Reuters) - Drugmaker AstraZeneca (AZN.L), opens new tab said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, ...
Hosted on MSN
Children’s asthma attacks cut nearly in half with 2-in-1 inhaler according to new study
A new study led by the Medical Research Institute of New Zealand (MRINZ) has found that asthmatic children don't face any additional risk from using inhalers currently reserved for teens and adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback